This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| bacteriophage | |
|---|---|
| Name | Bacteriophage |
bacteriophage Bacteriophages are viruses that infect bacteria and are found across Earth, including environments studied by Charles Darwin, Alexander von Humboldt, Louis Pasteur, Antonie van Leeuwenhoek, and modern researchers at institutions such as Harvard University, Massachusetts Institute of Technology, University of Oxford, Stanford University, and California Institute of Technology. They were explored in early work by scientists at the Pasteur Institute, Institut Pasteur, Institut Pasteur de Lille, and later in studies associated with Cold Spring Harbor Laboratory, The Rockefeller University, Max Planck Society, and National Institutes of Health. Research on bacteriophages informs fields linked to discoveries at the Royal Society, Académie des sciences, National Academy of Sciences, Nobel Prize contexts, and collaborations involving Wellcome Trust, Howard Hughes Medical Institute, Bill & Melinda Gates Foundation, and European Molecular Biology Laboratory.
Bacteriophages were first studied in experiments performed by laboratories including the Institut Pasteur and researchers such as those linked to Frederick Twort and Félix d'Hérelle whose work ran alongside institutions like University of Cambridge, University of Paris, Johns Hopkins University, Yale University, and Columbia University. Major historical developments intersect with events at the World Health Organization, United Nations, Cold War, Second World War, and policy shifts influenced by organizations like U.S. Food and Drug Administration and European Medicines Agency. Contemporary phage research connects to initiatives at DARPA, National Science Foundation, Bill & Melinda Gates Foundation, and consortia such as the Human Microbiome Project and projects led by Venter Institute.
Phage morphology was detailed in structural biology studies at centers like European Synchrotron Radiation Facility, Argonne National Laboratory, Lawrence Berkeley National Laboratory, Brookhaven National Laboratory, and crystallography work related to laureates such as Dorothy Crowfoot Hodgkin, Max Perutz, John Kendrew, Aaron Klug, and Rosalind Franklin. Structural categories observed using equipment from Nobel Prize-linked labs include tailed phages resembling models studied by groups at Howard Hughes Medical Institute, filamentous forms characterized in studies at Salk Institute for Biological Studies, and icosahedral capsids resolved by teams at European Molecular Biology Laboratory, Riken, and National Institutes of Health. High-resolution imaging efforts have paralleled methods employed at European XFEL, SLAC National Accelerator Laboratory, Oxford Nanopore Technologies, and collaborations with companies such as Thermo Fisher Scientific.
Phage life cycles—lytic, lysogenic, chronic, and pseudolysogenic—were elucidated by researchers connected with academic centers including University of California, Berkeley, Massachusetts Institute of Technology, Princeton University, University of Chicago, and University of Michigan. Genetic control mechanisms resonate with findings from laboratories of Francis Crick, James Watson, Rosalind Franklin, Sydney Brenner, Walter Gilbert, and institutions like Cold Spring Harbor Laboratory, Sanger Institute, Max Planck Institute for Molecular Genetics, and European Bioinformatics Institute. Molecular techniques applied in replication studies have parallels with tools developed at Genentech, Amgen, Novartis, Pfizer, and biotech firms collaborating with universities such as UCSF.
Phage diversity has been cataloged by initiatives at International Committee on Taxonomy of Viruses, National Center for Biotechnology Information, European Nucleotide Archive, DNA Data Bank of Japan, and bioinformatics groups at EMBL-EBI, Broad Institute, JGI, and Wellcome Sanger Institute. Classification schemes reference historical taxonomists linked to Carl Linnaeus, and modern methods incorporate metagenomics approaches from projects led by Craig Venter, Eugene Koonin, Rudolf Jaenisch, and consortia involving NASA Astrobiology Institute and Global Virome Project.
Ecological roles of phages have been explored in environments studied by expeditions linked to HMS Beagle, Challenger expedition, Sverdrup Expedition, and research aboard vessels affiliated with Woods Hole Oceanographic Institution, Scripps Institution of Oceanography, Monterey Bay Aquarium Research Institute, and Alfred Wegener Institute. Phage-driven evolution is analyzed alongside theories from Charles Darwin, Theodosius Dobzhansky, Motoo Kimura, and population genetics work at University of California, San Diego, Princeton University, Cold Spring Harbor Laboratory, and Institute Pasteur. Studies intersect with public health events such as 1918 influenza pandemic analyses and modern surveillance by Centers for Disease Control and Prevention.
Phage-bacteria interactions inform microbiological research carried out at University of Cambridge, John Innes Centre, ETH Zurich, Max Planck Institute for Infection Biology, Imperial College London, and medical centers like Mayo Clinic, Cleveland Clinic, Massachusetts General Hospital, Karolinska Institute, and Nuffield Department of Medicine. Mechanisms such as CRISPR were characterized by scientists affiliated with Emmanuelle Charpentier, Jennifer Doudna, and institutions including University of California, Berkeley and Max Planck Society. Phage therapy case studies have involved hospitals connected to NHS, Hôpital Européen Georges-Pompidou, Sheba Medical Center, and regulatory discussions with European Medicines Agency and U.S. Food and Drug Administration.
Applied phage research spans companies and institutions such as PhageTech, Intralytix, Adaptive Phage Therapeutics, AmpliPhi Biosciences, Eli Lilly and Company, GSK, Johnson & Johnson, Takeda Pharmaceutical Company, Roche, and collaborations with universities including Johns Hopkins University, University of Pennsylvania, University of Toronto, and McMaster University. Clinical trials and compassionate use have been coordinated through hospitals like University Hospital Ghent, Hospital of the University of Pennsylvania, UCSF Medical Center, and research networks supported by National Institutes of Health, European Commission, Wellcome Trust, and philanthropic entities such as Gates Foundation. Emerging uses involve synthetic biology approaches at MIT Media Lab, Wyss Institute, Broad Institute, and industrial partnerships with Illumina, Agilent Technologies, and Thermo Fisher Scientific.